Related references
Note: Only part of the references are listed.Placebo Response in Rheumatoid Arthritis Clinical Trials
Katie Bechman et al.
JOURNAL OF RHEUMATOLOGY (2020)
Sharing Historical Trial Data to Accelerate Clinical Development
Perry T. Yin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Global migration of clinical research during the era of trial registration
Paul K. Drain et al.
PLOS ONE (2018)
Rheumatoid arthritis
Josef S. Smolen et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
When will clinical trials finally reflect diversity?
Todd C. Knepper et al.
NATURE (2018)
When clinical trials compete: prioritising study recruitment
Luke Gelinas et al.
JOURNAL OF MEDICAL ETHICS (2017)
Geographic Variations in Controlled Trials
Aaron L. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Adverse Events as End Points: The Need to Account for Both Sides of the Same Coin
Felipe Aizpuru
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated Collection
Patricia O. Guimares et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Globalization and changing trends of biomedical research output
Marisa L. Conte et al.
JCI INSIGHT (2017)
In wealthier countries, patients perceive worse impact of the disease although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study
Polina Putrik et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Comparative rates of harms in randomized trials from more developed versus less developed countries may be different
Despina Contopoulos-Ioannidis et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
The Anatomy of Medical Research US and International Comparisons
Hamilton Moses et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials
Joshua D. Grill et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?
Polina Putrik et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Rheumatoid arthritis in the developing world: stepping up to the challenge
Bridget Hodkinson et al.
CLINICAL RHEUMATOLOGY (2014)
Global migration of clinical trials
Paul K. Drain et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Re-inventing clinical trials through TransCelerate
Dalvir Gill
NATURE REVIEWS DRUG DISCOVERY (2014)
Randomized Controlled Trials of Rheumatoid Arthritis Registered at ClinicalTrials.gov
Nasim A. Khan et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution?
Bassel El Zorkany et al.
CLINICAL RHEUMATOLOGY (2013)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
Clinical trials in rheumatoid arthritis: a status report from the ClinicalTrials.gov website
Jisna R. Paul et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Impact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled study
Eduard Vieta et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
So Different, yet So Similar: Meta-Analysis and Policy Modeling of Willingness to Participate in Clinical Trials among Brazilians and Indians
Guilherme Zammar et al.
PLOS ONE (2010)
Ethical and Scientific Implications of the Globalization of Clinical Research
Seth W. Glickman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
